C. Matthew McMurdo's most recent trade in Minim Inc was a trade of 159,364 Common Stock done . Disclosure was reported to the exchange on Sept. 26, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Minim Inc | Matthew C. McMurdo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 159,364 | 184,364 | - | - | Common Stock | |
Opgen Inc | Matthew C. McMurdo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2024 | 100,000 | 100,000 (1%) | 1% | - | Common Stock | |
Minim Inc | C. Matthew McMurdo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 25,000 | 25,000 | - | - | Common Stock | |
Titan Pharmaceuticals, Inc... | Matthew C. McMurdo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2023 | 100,000 | 100,000 | - | - | Option to Purchase Common Stock | |
Titan Pharmaceuticals, Inc... | Matthew C. McMurdo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2023 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
Titan Pharmaceuticals, Inc... | Matthew C. McMurdo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2023 | 25,000 | 25,000 | - | - | Option to Purchase Common Stock |